The wearable neurostimulation devices market size has grown rapidly in recent years. It will grow from $0.67 billion in 2025 to $0.75 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising awareness of non-invasive therapies, growth in home-based treatment adoption, advancements in wearable electronics, expanding clinical research in neuromodulation.
The wearable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing investments in digital therapeutics, rising demand for personalized neurological treatments, expansion of remote patient monitoring adoption, growing integration of neuro devices with mobile health platforms, increasing regulatory approvals for wearable neurostimulation devices. Major trends in the forecast period include increasing adoption of at-home neurostimulation therapies, rising use of wearable brain stimulation devices, growing integration of ai-based signal optimization, expansion of wireless and portable neuro devices, enhanced focus on personalized neuromodulation.
The rising prevalence of neurological disorders is expected to drive significant growth in the wearable neurostimulation devices market. Neurological disorders are conditions that impact the brain, spinal cord, and nervous system, leading to symptoms such as cognitive, motor, and sensory impairments. This growing prevalence is largely attributed to the aging global population, as aging contributes to reduced brain plasticity, increased oxidative stress, and declining neuronal function, all of which elevate the risk of neurological conditions. Wearable neurostimulation devices offer a non-invasive therapeutic option that supports the daily management of these disorders. By delivering targeted stimulation, these devices help alleviate symptoms, enhance patient comfort, and improve quality of life. For example, in July 2024, the UK’s National Health Service reported that 487,432 individuals were diagnosed with dementia in June 2024 an increase of 3,155 cases from May 2024. Thus, the rising number of neurological disorders is propelling the growth of the wearable neurostimulation devices market.
Key players in the wearable neurostimulation devices market are focusing on launching innovative products, such as sleep-on-demand headbands, to improve sleep quality and manage sleep-related conditions. These headbands use neurostimulation or soothing sensory input (like audio or vibration) to help users fall asleep faster and support relaxation by enhancing brainwave patterns associated with sleep. For instance, in June 2024, Elemind Technologies Inc., a US-based neurotechnology company, introduced the Elemind Headband a first-of-its-kind neurostimulation device designed for sleep-on-demand use. The headband utilizes technologies such as transcranial direct current stimulation (tDCS) to modulate brain activity. It applies gentle electrical currents through electrodes placed on the scalp, stimulating specific brain regions associated with relaxation or cognitive function. This innovation helps improve mental clarity, reduce stress, and enhance sleep quality, depending on the selected mode.
In September 2023, Amber Therapeutics, a UK-based neuromodulation therapy provider, acquired Bioinduction for an undisclosed amount. This strategic acquisition grants Amber access to advanced hardware, technical expertise, and manufacturing capabilities, allowing the company to accelerate the development and commercialization of its Amber-UI system. Bioinduction, also based in the UK, specializes in the production of wearable neurostimulation devices, and its integration into Amber’s operations marks a key step in scaling next-generation neuromodulation solutions.
Major companies operating in the wearable neurostimulation devices market are FocusCalm, Cala Health Inc., Cognito Therapeutics Inc., Apollo Neuroscience Inc., Curonix LLC, Soterix Medical Inc., Theranica Bioelectronics Ltd., NeuroMetrix Inc., Spark Biomedical Inc., Helius Medical Technologies Inc., Hapbee Technologies Inc., Flow Neuroscience, tVNS Technologies GmbH, Wearable Devices Ltd., MindMaze SA, Emotiv Inc., NextMind (Snap Inc.), Neuroelectrics Barcelona S.L., Brain Scientific Inc., Neurosity Inc.
North America was the largest region in the wearable neurostimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the wearable neurostimulation devices market by increasing costs of imported semiconductors, microcontrollers, sensors, batteries, and advanced electronic components used in EEG, TMS, BCI, and neurostimulation devices. North America and Europe are particularly affected due to reliance on imported electronics, while Asia-Pacific faces higher production costs for export-driven manufacturing. These tariffs are increasing device prices and slowing adoption in homecare settings. At the same time, they are encouraging local electronics manufacturing, regional device assembly, and greater investment in software-driven differentiation to offset hardware cost pressures.
The wearable neurostimulation devices market research report is one of a series of new reports that provides wearable neurostimulation devices market statistics, including wearable neurostimulation devices industry global market size, regional shares, competitors with a wearable neurostimulation devices market share, detailed wearable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable neurostimulation devices industry. This wearable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Wearable neurostimulation devices are portable electronic devices designed to deliver targeted electrical stimulation to the brain or nervous system. These devices aim to modulate brain activity to improve cognitive function, manage pain, or treat neurological conditions such as depression, anxiety, and chronic pain. They are typically used for at-home therapy with minimal supervision.
The main product types in the wearable neurostimulation devices market include electroencephalography (EEG) devices, transcranial magnetic stimulation (TMS) devices, brain-computer interface (BCI) devices, neurostimulation devices, and cognitive training devices. Electroencephalography (EEG) devices are medical or research tools that monitor brain activity by recording voltage fluctuations resulting from ionic current flows within neurons. These devices are used in various applications, including stroke, spinal cord injury, and cerebral palsy, among others. The key end-users of these devices include rehabilitation centers, hospitals, clinics, and other healthcare facilities.
The wearable neurostimulation devices market consists of revenues earned by entities by providing services such as device sales, maintenance and support, data analytics, therapy customization, remote monitoring, patient education and subscription-based health management. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable neurostimulation devices market also includes sales of cranial electrotherapy stimulation (CES) devices, vagus nerve stimulation (VNS) devices, spinal cord stimulation (SCS) devices, functional electrical stimulation (FES) devices, peripheral nerve stimulation (PNS) devices and deep brain stimulation (DBS) devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The wearable neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $1.22 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing investments in digital therapeutics, rising demand for personalized neurological treatments, expansion of remote patient monitoring adoption, growing integration of neuro devices with mobile health platforms, increasing regulatory approvals for wearable neurostimulation devices. Major trends in the forecast period include increasing adoption of at-home neurostimulation therapies, rising use of wearable brain stimulation devices, growing integration of ai-based signal optimization, expansion of wireless and portable neuro devices, enhanced focus on personalized neuromodulation.
The rising prevalence of neurological disorders is expected to drive significant growth in the wearable neurostimulation devices market. Neurological disorders are conditions that impact the brain, spinal cord, and nervous system, leading to symptoms such as cognitive, motor, and sensory impairments. This growing prevalence is largely attributed to the aging global population, as aging contributes to reduced brain plasticity, increased oxidative stress, and declining neuronal function, all of which elevate the risk of neurological conditions. Wearable neurostimulation devices offer a non-invasive therapeutic option that supports the daily management of these disorders. By delivering targeted stimulation, these devices help alleviate symptoms, enhance patient comfort, and improve quality of life. For example, in July 2024, the UK’s National Health Service reported that 487,432 individuals were diagnosed with dementia in June 2024 an increase of 3,155 cases from May 2024. Thus, the rising number of neurological disorders is propelling the growth of the wearable neurostimulation devices market.
Key players in the wearable neurostimulation devices market are focusing on launching innovative products, such as sleep-on-demand headbands, to improve sleep quality and manage sleep-related conditions. These headbands use neurostimulation or soothing sensory input (like audio or vibration) to help users fall asleep faster and support relaxation by enhancing brainwave patterns associated with sleep. For instance, in June 2024, Elemind Technologies Inc., a US-based neurotechnology company, introduced the Elemind Headband a first-of-its-kind neurostimulation device designed for sleep-on-demand use. The headband utilizes technologies such as transcranial direct current stimulation (tDCS) to modulate brain activity. It applies gentle electrical currents through electrodes placed on the scalp, stimulating specific brain regions associated with relaxation or cognitive function. This innovation helps improve mental clarity, reduce stress, and enhance sleep quality, depending on the selected mode.
In September 2023, Amber Therapeutics, a UK-based neuromodulation therapy provider, acquired Bioinduction for an undisclosed amount. This strategic acquisition grants Amber access to advanced hardware, technical expertise, and manufacturing capabilities, allowing the company to accelerate the development and commercialization of its Amber-UI system. Bioinduction, also based in the UK, specializes in the production of wearable neurostimulation devices, and its integration into Amber’s operations marks a key step in scaling next-generation neuromodulation solutions.
Major companies operating in the wearable neurostimulation devices market are FocusCalm, Cala Health Inc., Cognito Therapeutics Inc., Apollo Neuroscience Inc., Curonix LLC, Soterix Medical Inc., Theranica Bioelectronics Ltd., NeuroMetrix Inc., Spark Biomedical Inc., Helius Medical Technologies Inc., Hapbee Technologies Inc., Flow Neuroscience, tVNS Technologies GmbH, Wearable Devices Ltd., MindMaze SA, Emotiv Inc., NextMind (Snap Inc.), Neuroelectrics Barcelona S.L., Brain Scientific Inc., Neurosity Inc.
North America was the largest region in the wearable neurostimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wearable neurostimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the wearable neurostimulation devices market by increasing costs of imported semiconductors, microcontrollers, sensors, batteries, and advanced electronic components used in EEG, TMS, BCI, and neurostimulation devices. North America and Europe are particularly affected due to reliance on imported electronics, while Asia-Pacific faces higher production costs for export-driven manufacturing. These tariffs are increasing device prices and slowing adoption in homecare settings. At the same time, they are encouraging local electronics manufacturing, regional device assembly, and greater investment in software-driven differentiation to offset hardware cost pressures.
The wearable neurostimulation devices market research report is one of a series of new reports that provides wearable neurostimulation devices market statistics, including wearable neurostimulation devices industry global market size, regional shares, competitors with a wearable neurostimulation devices market share, detailed wearable neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the wearable neurostimulation devices industry. This wearable neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Wearable neurostimulation devices are portable electronic devices designed to deliver targeted electrical stimulation to the brain or nervous system. These devices aim to modulate brain activity to improve cognitive function, manage pain, or treat neurological conditions such as depression, anxiety, and chronic pain. They are typically used for at-home therapy with minimal supervision.
The main product types in the wearable neurostimulation devices market include electroencephalography (EEG) devices, transcranial magnetic stimulation (TMS) devices, brain-computer interface (BCI) devices, neurostimulation devices, and cognitive training devices. Electroencephalography (EEG) devices are medical or research tools that monitor brain activity by recording voltage fluctuations resulting from ionic current flows within neurons. These devices are used in various applications, including stroke, spinal cord injury, and cerebral palsy, among others. The key end-users of these devices include rehabilitation centers, hospitals, clinics, and other healthcare facilities.
The wearable neurostimulation devices market consists of revenues earned by entities by providing services such as device sales, maintenance and support, data analytics, therapy customization, remote monitoring, patient education and subscription-based health management. The market value includes the value of related goods sold by the service provider or included within the service offering. The wearable neurostimulation devices market also includes sales of cranial electrotherapy stimulation (CES) devices, vagus nerve stimulation (VNS) devices, spinal cord stimulation (SCS) devices, functional electrical stimulation (FES) devices, peripheral nerve stimulation (PNS) devices and deep brain stimulation (DBS) devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Wearable Neurostimulation Devices Market Characteristics
3. Wearable Neurostimulation Devices Market Supply Chain Analysis
4. Global Wearable Neurostimulation Devices Market Trends and Strategies
5. Wearable Neurostimulation Devices Market Analysis of End Use Industries
7. Global Wearable Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Wearable Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Wearable Neurostimulation Devices Market Segmentation
10. Wearable Neurostimulation Devices Market Regional and Country Analysis
11. Asia-Pacific Wearable Neurostimulation Devices Market
12. China Wearable Neurostimulation Devices Market
13. India Wearable Neurostimulation Devices Market
14. Japan Wearable Neurostimulation Devices Market
15. Australia Wearable Neurostimulation Devices Market
16. Indonesia Wearable Neurostimulation Devices Market
17. South Korea Wearable Neurostimulation Devices Market
18. Taiwan Wearable Neurostimulation Devices Market
19. South East Asia Wearable Neurostimulation Devices Market
20. Western Europe Wearable Neurostimulation Devices Market
21. UK Wearable Neurostimulation Devices Market
22. Germany Wearable Neurostimulation Devices Market
23. France Wearable Neurostimulation Devices Market
24. Italy Wearable Neurostimulation Devices Market
25. Spain Wearable Neurostimulation Devices Market
26. Eastern Europe Wearable Neurostimulation Devices Market
27. Russia Wearable Neurostimulation Devices Market
28. North America Wearable Neurostimulation Devices Market
29. USA Wearable Neurostimulation Devices Market
30. Canada Wearable Neurostimulation Devices Market
31. South America Wearable Neurostimulation Devices Market
32. Brazil Wearable Neurostimulation Devices Market
33. Middle East Wearable Neurostimulation Devices Market
34. Africa Wearable Neurostimulation Devices Market
36. Wearable Neurostimulation Devices Market Competitive Landscape and Company Profiles
37. Wearable Neurostimulation Devices Market Other Major and Innovative Companies
40. Wearable Neurostimulation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Wearable Neurostimulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses wearable neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for wearable neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wearable neurostimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Electroencephalography (EEG) Devices; Transcranial Magnetic Stimulation (TMS) Devices; Brain Computer Interface (BCI) Devices; Neurostimulation Devices; Cognitive Training Devices2) By Application: Stroke; Spinal Cord Injury; Cerebral Palsy; Other Applications
3) By End-User: Rehabilitation Centers; Hospitals And Clinics; Other End-Users
Subsegments:
1) By Electroencephalography (EEG) Devices: Portable Electroencephalography (EEG) Devices; Wireless Electroencephalography (EEG) Devices; Mobile Electroencephalography (EEG) Devices; Clinical Electroencephalography (EEG) Devices2) By Transcranial Magnetic Stimulation (TMS) Devices: Single-Pulse Transcranial Magnetic Stimulation (TMS); Repetitive Transcranial Magnetic Stimulation (rTMS); Deep Transcranial Magnetic Stimulation (TMS); Theta Burst Stimulation (TBS) Transcranial Magnetic Stimulation (TMS)
3) By Brain Computer Interface (BCI) Devices: Non-invasive Brain Computer Interface (BCI) Devices; Partially Invasive Brain Computer Interface (BCI) Devices
4) By Neurostimulation Devices: Transcranial Direct Current Stimulation (tDCS) Devices; Transcranial Alternating Current Stimulation (tACS) Devices; Peripheral Nerve Stimulation (PNS) Devices
5) By Cognitive Training Devices: Memory Training Devices; Attention Training Devices; Neurofeedback Devices; Brain Training Games
Companies Mentioned: FocusCalm; Cala Health Inc.; Cognito Therapeutics Inc.; Apollo Neuroscience Inc.; Curonix LLC; Soterix Medical Inc.; Theranica Bioelectronics Ltd.; NeuroMetrix Inc.; Spark Biomedical Inc.; Helius Medical Technologies Inc.; Hapbee Technologies Inc.; Flow Neuroscience; tVNS Technologies GmbH; Wearable Devices Ltd.; MindMaze SA; Emotiv Inc.; NextMind (Snap Inc.); Neuroelectrics Barcelona S.L.; Brain Scientific Inc.; Neurosity Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Wearable Neurostimulation Devices market report include:- FocusCalm
- Cala Health Inc.
- Cognito Therapeutics Inc.
- Apollo Neuroscience Inc.
- Curonix LLC
- Soterix Medical Inc.
- Theranica Bioelectronics Ltd.
- NeuroMetrix Inc.
- Spark Biomedical Inc.
- Helius Medical Technologies Inc.
- Hapbee Technologies Inc.
- Flow Neuroscience
- tVNS Technologies GmbH
- Wearable Devices Ltd.
- MindMaze SA
- Emotiv Inc.
- NextMind (Snap Inc.)
- Neuroelectrics Barcelona S.L.
- Brain Scientific Inc.
- Neurosity Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.75 Billion |
| Forecasted Market Value ( USD | $ 1.22 Billion |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
